The present invention provides curable calcium phosphate dental cement that has excellent sealability for dentinal tubule, is expected to form fluoroapatite, and has a curing time that is advantageous for clinical use. The present invention is directed to curable calcium phosphate dental cement including: a first material as powder or nonaqueous paste; and a second material as liquid or aqueous paste, and, in the curable calcium phosphate dental cement, the first material comprises tetracalcium phosphate (A), alkali metal salt of phosphoric acid (B), and acidic calcium phosphate (C), the second material comprises water (D), and at least one of the first material and the second material comprises a fluorine compound (E) and an organic acid (F) having a molecular weight of 10000 or less.

The present disclosure features adhesive compositions and methods of use thereof related to the medical, veterinary, and dental fields.

The present disclosure features adhesive compositions and methods of use thereof related to the medical, veterinary, and dental fields.

Provided herein are compositions and their methods of use to adhere (e.g., in wet and dry environments) a variety of materials together.

Various embodiments of tantalum- and/or niobium-containing glasses and cements as well as uses thereof are described herein. For example, in an embodiment, the glasses comprise a transition metal pentoxide such as tantalum pentoxide and/or niobium pentoxide present in the glass in an amount of less than 2.0 mol %, based on the total composition of the glass, glass polyalkenoate cements prepared from such glasses and uses of such cements, for example, for sternal closure or fixation, stabilization and/or repair of a fracture in a bone in the wrist, elbow, knee, shoulder, spine and/or hip.

Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.

Biphasic self-setting calcium phosphate (SSCP) used for bone graft material and dental material applications having shape formability, shape retentivity, and bone replacement properties in addition to biocompatibility, safety, non-infectiousness, and absence of outflow, wherein the work time for forming the shape of a kneaded material obtained by kneading biphasic SSCP powder and biphasic SSCP liquid is controlled. A method for controlling the work time for forming the shape of biphasic SSCP in which the moldable work time from the start of kneading to the setting of the kneaded material is adjusted to within a range of from 10 seconds to 600 seconds by kneading a biphasic SSCP powder and biphasic SSCP liquid, the biphasic SSCP powder comprising tetracalcium phosphate and -tricalcium phosphate and the biphasic SSCP liquid comprising a phosphoric acid aqueous solution containing a calcium component.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.

The present invention generally relates to the use of pre-formed bodies of Chemically Bonded Ceramics (CBCs) biomaterial for implantation purposes wherein the bodies are prepared ex vivo allowing process parameters to be optimized for desired long term properties of the resulting CBC biomaterial. More particularly, the pre-formed CBC material bodies of the present invention are sintered. The pre-formed body of CBC material is machined to the desired geometry and then implanted using a CBC cementation paste for fixation of the body to tissue. The invention also relates to a method of preparing pre-formed bodies of CBC biomaterial for implantation purposes, methods of preparing an implant thereof having desired geometry, and a method of implantation of the implant, as well as a kit for use in the method of implantation.